Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the impact of two interventions against
insulin resistance on the composite endpoint of 10% improvement in baseline six minute walk
distance or improvement in World Health Organization (WHO) functional class in humans with
pulmonary artery hypertension (PAH).